Current Status of Radical Prostatectomy for High-Risk Prostate Cancer.
10.4111/kju.2014.55.10.629
- Author:
Ho Won KANG
1
;
Joo Yong LEE
;
Jong Kyou KWON
;
Seong Uk JEH
;
Hae Do JUNG
;
Young Deuk CHOI
Author Information
1. Department of Urology, Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea. youngd74@yuhs.ac
- Publication Type:Review ; Research Support, Non-U.S. Gov't
- Keywords:
Prostatectomy;
Prostatic neoplasms;
Survival;
Treatment outcome
- MeSH:
Combined Modality Therapy;
Humans;
Male;
Prostatectomy/*methods;
Prostatic Neoplasms/*surgery/therapy;
Robotic Surgical Procedures/methods;
Treatment Outcome
- From:Korean Journal of Urology
2014;55(10):629-635
- CountryRepublic of Korea
- Language:English
-
Abstract:
Despite the wide application of prostate-specific antigen-based screening leading to a profound stage migration in prostate cancer (PC), a significant percentage of men are still being diagnosed with clinically high-risk disease that requires aggressive treatment. Optimal management in these patients remains challenging, and strong advocates for radical prostatectomy (RP), radiotherapy, androgen deprivation therapy, and, increasingly, a multimodal approach abound. Currently, surgery for high-risk PC is frequently applied. RP offers an attractive opportunity for tumor excision either as a definitive management or as a first step in multimodal therapy. Nevertheless, this approach is still controversial. In this review, we discuss the current evidence for the role of RP in this clinical setting, including surgical considerations and outcomes. The role of robot-assisted RP, which is increasingly utilized in Korea in this clinical scenario, is discussed.
